Advanced search
Publication Cover
Acta Cardiologica Volume 79, 2024 - Issue 2
Submit an article Journal homepage
42
Views
1
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Serum circRNA (Circ)_0051386 assists in the diagnosis of acute ST-segment elevation myocardial infarction and prediction of the occurrence of major adverse cardiovascular events after percutaneous coronary intervention

Jinlin Xua Emergency Department, Xiantao First People’s Hospital, Xiantao, ChinaView further author information
,
Zhiwei Wanga Emergency Department, Xiantao First People’s Hospital, Xiantao, ChinaView further author information
,
Yu Aia Emergency Department, Xiantao First People’s Hospital, Xiantao, ChinaCorrespondence[email protected]
View further author information
&
Ye Wenb Emergency Department, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, ChinaCorrespondence[email protected]
View further author information
Pages 215-223 | Received 29 Mar 2023, Accepted 21 Feb 2024, Published online: 08 Mar 2024

References

  • Sulo G, et al. Trends in incident acute myocardial infarction in Norway: an updated analysis to 2014 using national data from the CVDNOR project. Eur J Prev Cardiol. 2018;25(10):1031–1039. doi:10.1177/2047487318780033.
  • Ioacara S, Popescu AC, Tenenbaum J, et al. Acute myocardial infarction mortality rates and trends in Romania between 1994 and 2017. Int J Environ Res Public Health. 2017;681, 1–9.
  • GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788. doi:10.1016/S0140-6736(18)32203-7.
  • Rathod KS, Comer K, Casey-Gillman O, et al. Early hospital discharge following PCI for patients with STEMI. J Am Coll Cardiol. 2021;78(25):2550–2560. doi:10.1016/j.jacc.2021.09.1379.
  • Zhai C, Qian G, Wu H, et al. Knockdown of circ_0060745 alleviates acute myocardial infarction by suppressing NF-κB activation. J Cell Mol Med. 2020;24(21):12401–12410. doi:10.1111/jcmm.15748.
  • Yang W, Sun L, Cao X, et al. Detection of circRNA biomarker for acute myocardial infarction based on system biological analysis of RNA expression. Front Genet. 2021;12:686116. doi:10.3389/fgene.2021.686116.
  • Gao T, Peng X, Yang D, et al. CircSMARCC1 and CircLRBA are potential biomarkers in forensic postmortem diagnosis of acute myocardial infarction. Leg Med. 2022;60:102184. doi:10.1016/j.legalmed.2022.102184.
  • Chang C-H, Lin C-H, Lane H-Y. Machine learning and novel biomarkers for the diagnosis of Alzheimer’s disease. Int J Mol Sci. 2021;22(5):2761. doi:10.3390/ijms22052761.
  • Vogel B, et al. ST-segment elevation myocardial infarction. Nat Rev Dis Prim. 2019;5:39.
  • Chen T, Zhang X, Qian W, et al. Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention. Bioengineered. 2022;13(4):8266–8276. doi:10.1080/21655979.2022.2051885.
  • Jaffe AS, Ravkilde J, Roberts R, et al. It’s time for a change to a troponin standard. Circulation. 2000;102(11):1216–1220. doi:10.1161/01.cir.102.11.1216.
  • Zhang Z, Yang T, Xiao J. Circular RNAs: promising biomarkers for human diseases. EBioMedicine. 2018;34:267–274. doi:10.1016/j.ebiom.2018.07.036.
  • Aydin S, Ugur K, Aydin S, et al. Biomarkers in acute myocardial infarction: current perspectives. Vasc Health Risk Manag. 2019;15:1–10. doi:10.2147/VHRM.S166157.
  • Sun Y, Wang M, Tan X, et al. Identification of oxidative Stress-Related biomarkers in acute myocardial infarction. Int J Gen Med. 2023;16:4805–4818. doi:10.2147/IJGM.S428709.
  • Zhao Y, Song X, Ma Y, et al. Circulating mir-483-5p as a novel diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI. BMC Cardiovasc Disord. 2023;23(1):360. doi:10.1186/s12872-023-03387-5.
  • Yang X, Du X, Ma K, et al. Circulating miRNAs related to long-term adverse cardiovascular events in STEMI patients: a nested case-control study. Can J Cardiol. 2021;37(1):77–85. doi:10.1016/j.cjca.2020.03.018.
  • Li J, Sun D, Li Y. Novel findings and therapeutic targets on cardioprotection of ischemia/reperfusion injury in STEMI. Curr Pharm Des. 2019;25(35):3726–3739. doi:10.2174/1381612825666191105103417.
  • Moreira DM, da Silva RL, Vieira JL, et al. Role of ­vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of ­atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Am J Cardiovasc Drugs. 2015;15(1):1–11. doi:10.1007/s40256-014-0094-z.
  • Fung EC, Butt AN, Eastwood J, et al. Circulating microRNA in cardiovascular disease. Adv Clin Chem. 2019;91:99–122. doi:10.1016/bs.acc.2019.03.003.
  • Schweiger V, et al. Non-coding RNAs in stem cell ­regulation and cardiac regeneration: current problems and future perspectives. Int J Mol Sci. 2021;22:9160.
  • Zheng H-F, Sun J, Zou Z-Y, et al. MiRNA-488-3p suppresses acute myocardial infarction-induced cardiomyocyte apoptosis via targeting ZNF791. Eur Rev Med Pharmacol Sci. 2019;23(11):4932–4939. doi:10.26355/eurrev_201906_18083.
  • Xing X, et al. miR-26a-5p protects against myocardial ischemia/reperfusion injury by regulating the PTEN/PI3K/AKT signaling pathway. Braz J Med Biol Res. 2020;53:e9106.
  • Liang H, Su X, Wu Q, et al. LncRNA 2810403D21Rik/mirf promotes ischemic myocardial injury by regulating autophagy through targeting Mir26a. Autophagy. 2020;16(6):1077–1091. doi:10.1080/15548627.2019.1659610.
  • Ren K, Li B, Jiang L, et al. Circ_0023461 silencing protects cardiomyocytes from Hypoxia-Induced dysfunction through targeting miR-370-3p/PDE4D signaling. Oxid Med Cell Longev. 2021;2021(2021):8379962. doi:10.1155/2021/8379962.
  • Wang G, Wang C, Huang Z, et al. Exosomal circ-0020887 and circ-0009590 as novel biomarkers for the diagnosis and prediction of short-term adverse cardiovascular outcomes in STEMI patients. Open Med. 2023;18(1):20230807. doi:10.1515/med-2023-0807.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.